Laura Perryman, former CEO of neurostimulation device maker Stimwave, was arrested in Florida on Thursday after being accused of running a yearslong scheme to defraud …
Applied Molecular Transport has already sacrificed a lot last year to keep its chronic pouchitis treatment on track—including 40% of its staff and early-stage pipeline …
The FDA’s nascent Safer Technologies Program, or STeP, is getting a major glow-up. Half a decade after first proposing the program—which aims to speed up …
A common treatment for the breathlessness experienced by many people with chronic obstructive pulmonary disease (COPD) relies on the use of a positive-expiratory pressure (PEP) …
A surgical robot system developed by Noah Medical and newly cleared by the FDA is out of this world—or, at least, the current world of …
Just over a year after lining up another $3.4 billion to keep developing new tools and technologies toward its long-standing goal of honing our knowledge …
When Veru swiftly wrapped up a phase 3 trial of its COVID treatment last April, expectations bubbled that the company may be able to pry …
Viz.ai is already an old hand at putting its disease-spotting artificial intelligence algorithms through the FDA review process, having secured the agency’s sign-off for seven …
At the end of 2019, Olympus outlined an updated game plan for its medical device business, directing its focus toward gastrointestinal, urological and respiratory care, …
There are no treatments for aortic stenosis, a heart valve problem afflicting as many as a fifth of people over 65. The only solution is …
Insulet broke new ground in 2021 as its annual revenues surged past the $1 billion mark for the first time—even without a splashy new product …
Nearly two years after submitting its MiniMed 780G insulin delivery system to the FDA for clearance, Medtronic is still awaiting the agency’s nod—though not for …
Destiny Pharma could be in line for $570 million thanks to a new co-development agreement with U.S.-based Sebela Pharmaceuticals for a Clostridium difficile treatment. The …
Moderna had high hopes for its first seasonal flu vaccine to enter the clinic, but, so far, the mRNA shot hasn’t quite lived up to the …
Pfizer and Valneva’s phase 3 Lyme disease vaccine clinical trial has gone badly wrong. After discovering good clinical practice (GCP) violations at some trial sites, …
Robinow syndrome disorders are very rare, but their consequences can be profound. Babies born with the genetic condition often have a cleft palate and develop …
A vulnerability found in software used to monitor some of BD’s infusion pumps could potentially give hackers access to personal data stored in the system. …
Medtronic was found guilty this week of infringing a patent concerning transcatheter aortic valve replacement (TAVR) systems that was awarded to Colibri Heart Valve in …
Surgeons have about four hours from the moment a heart is removed from the donor to transplanting the heart into a patient. After that, the …
Two long-standing makers of implants and surgical tools for orthopedic procedures are set to combine into a single musculoskeletal device powerhouse. NuVasive and Globus Medical …
